Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib
对于接受硼替佐米治疗的AL淀粉样变性患者，加用环磷酰胺和更高剂量的地塞米松并不能改善预后。
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/bcj.2017.47
Kastritis, E; Gavriatopoulou, M; Roussou, M; Fotiou, D; Ziogas, D C; Migkou, M; Eleutherakis-Papaiakovou, E; Panagiotidis, I; Kanellias, N; Psimenou, E; Papadopoulou, E; Pamboucas, C; Manios, E; Gakiopoulou, H; Ntalianis, A; Tasidou, A; Giannouli, S; Terpos, E; Dimopoulos, M A
